Clinical trial
Dysport® In Migraine Without Aura Prophylaxis: DIMWAP Study
NCT00258609 · Department of Medical Services Ministry of Public Health of Thailand, Other · Completed
Key facts
| NCT number | NCT00258609 |
|---|---|
| Title | Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study |
| Official title | A 12-week Prospective, Double-blinded, Randomized, Multicenter Study of Low Dose and Medium Dose Botulinum Toxin Type A (Dysport® ) Injection for Migraine Prophylaxis. |
| Lead sponsor | Department of Medical Services Ministry of Public Health of Thailand, Other |
| Collaborators | Ipsen Industry Chiang Mai University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine Without Aura Prophylaxis |
| Intervention type | Drug |
| Interventions | Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection |
| Enrollment | 128 |
| Start date | Feb 1, 2003 |
| Completion | Jun 1, 2004 |
| First posted | Nov 24, 2005 |
| Last update posted | Feb 18, 2019 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: